Sat Nov 09 16:57:53 UTC 2024: ## COVID-19 Vaccine Linked to Rare Blood Disorder: Study
**Nanjing, China -** A new study published in the journal Frontiers of Medicine has revealed a potential association between the inactivated COVID-19 vaccine CoronaVac and immune thrombotic thrombocytopenic purpura (TTP), a rare and potentially life-threatening blood disorder.
The study, conducted by researchers at the Institute of Health and Technology Assessment (ISTA), detailed two cases of TTP occurring shortly after individuals received their second dose of CoronaVac. Both patients experienced symptoms such as fever, muscle soreness, dizziness, weakness, and low platelet count, eventually leading to a diagnosis of TTP. Both cases responded well to treatment with plasma exchange and immunosuppressive therapy.
The study also analyzed TTP incidence data from 14 hospitals in the Nanjing area, revealing an increase in TTP cases between 2019 and 2022, coinciding with the rollout of COVID-19 vaccination campaigns. While the study acknowledges the rarity of TTP, the observed increase in cases following vaccination suggests a possible link, though a direct causal relationship has not been established.
The study hypothesizes that the vaccine may trigger TTP through an autoimmune response that targets ADAMTS13, a protein crucial for blood clotting. A deficiency in ADAMTS13 can lead to the development of TTP.
The researchers emphasize the importance of timely and accurate diagnosis of TTP, as misdiagnosis can lead to inappropriate treatment and worsen the condition. They also highlight the critical role of plasma exchange and immunosuppressive therapy in managing TTP, as demonstrated by the successful treatment of the two cases in their study.
This study underscores the ongoing importance of monitoring potential side effects of COVID-19 vaccines, particularly rare and severe conditions like TTP. Further research is necessary to fully understand the potential link between the vaccine and TTP and to develop strategies for its prevention and treatment.